The frequencies of four malaria associated erythrocyte genetic abnormalities have been established in 1000 Omani subjects. They are: homozygous a + thalassaemia (-4/ -a) 0 45; high Hb A2 /1 thalassaemia trait 0-015; sickle trait (HbA/S) 0-061; and glucose 6 phosphate dehydrogenase deficiency (Gd-): males 0-27, females 0-11. From our data the a + (-a/) We can now report data on the frequencies of a and thalassaemia, sickle haemoglobin (Hb S), and glucose 6 phosphate dehydrogenase deficiency (Gd-) in nearly 1000 Omanis, a third of whom were healthy subjects.
Oman, situated in the south-east of the Arabian Peninsula, is a country of some 1 5 million people. The ethnic origin of the population is mainly Arab, but over the centuries considerable mixing has taken place with the East African and the Indian subcontinent. Interracial movement has come mostly via sea trade routes since Oman is geographically isolated from the rest of the Peninsula by a high mountain range along the western border. This separates it from the empty south-eastern desert quarter of Saudi Arabia.
A previous comparative study of the frequency of malaria associated erythrocyte genetic disorders in the Peninsular Arabs residing in the United Arab Emirates, namely UAE nationals, Saudis, Yemenis, and Omanis, indicated that in the Omanis the frequencies of two gene deletional type oa thalassaemia and glucose 6 phosphate dehydrogenase deficiency, 0 389 and 0 328 respectively, were far greater than in the other three Arab populations. Moreover they appeared to be among the highest in any country so far reported.' However, the number of subjects examined was too small to give accurate figures and, also, being an expatriate population the exact ethnic origin was uncertain.
We can now report data on the frequencies of a and thalassaemia, sickle haemoglobin (Hb S), and glucose 6 phosphate dehydrogenase deficiency (Gd-) in nearly 1000 Omanis, a third of whom were healthy subjects.
Subjects
Nine hundred and fifty-two Omani subjects, 435 males and 517 females, identified by tribal names, were studied. These comprised hospital patients (73%) and university students (27%). Of the hospital patients 83% were adults and the remainder children. To determine the frequencies of Hb S, Gd-, and : thalassaemia the whole population was studied. However, with regard to a thalassaemia only the male student population was studied in detail and the data extrapolated to predict the frequency in the population as a whole.
One hundred and forty-two 'non-Arab' subjects, 82 males and 60 females, who were healthy blood donors, were used as a control population for comparing the haematological parameters. They came from North America, Great Britain, Northern Europe, India, and the Philippines.
Methods
The routine blood counts were measured on a Coulter S Plus VI cell analyser. Haemoglobin A2 was measured using Helena Beta-thal and Sickle-thal ion exchange chromatography columns. The normal range for the Omani phenotype Hb A/Hb A for this laboratory was 1-8 to 3 5%. Values greater than 4 5% were accepted as being diagnostic of high Hb A2f thalassaemia trait.
Blood was screened for haemoglobin S using Ortho Sickledex kits. Haemoglobin electrophoresis was performed on all positive samples on agar gel at pH 86 and pH 60 using the Beckman Paragon system. Cord bloods were examined for the presence of Hb A, Hb S, and Hb Bart's by electrophoresis on agar gel at pH and pH 6- Figure 2 The distribution of the MCH among the Omani population studied. To population (black); male hospital patients (grey); Omani male students (white). populations are seen and are constant throughout the population, group A (MCH to 25 pg) and group B (MCH 25 to 32 pg). There is a slight overlap but the geometric means, 22-8 and 27-3 pg respectively, are significantly different (p < 0 06 HIGH HB A2 0i THALASSAEMIA The levels of Hb A2 were measured on 400 blood samples from the total population of 952 who had an MCH of less than 24 pg (group A). It was increased in 14 with values ranging from 4-5 to 5-6%. This gives an overall frequency of high Hb A2 ,B thalassaemia genes in the total population of 0-015. a THALASSAEMIA Because there is no simple diagnostic marker for a thalassaemia, and it is impractical to carry out DNA analysis on 1000 people, it was dek~4L. cided to select eight samples at random from patients whose haematological indices indicated a thalassaemia trait; namely an MCH of < 25 pg, a normal Hb A2, and a normal ferritin.
,tal These were then sent blind to another laboraTwo tory for a gene analysis. The results showed 14 that all eight patients were homozygous for the 91). a' deletional (-a/) thalassaemia gene (table 2) . Once confirmed, the frequency of the gene in Omanis could now be estimated with some degree of certainty by only measuring the MCH, Hb A2, and ferritin levels. For this we examined 127 of the male student population.
The MCH distribution pattern of this group is shown in fig 2. There were 63 students with a severe hypochromia with an MCH of 20 to 25 pg. Of these, 58 had normal ferritins of greater than 25 ng/ml and only one had a raised Hb A2. It was therefore assumed that the only cause of the hypochromia of the remaining 57 was homozygosity for a+ thalassaemia (-a/ -a) which gives a frequency among the male students of 57/127 = 0448. Since the relative size and MCH distribution of this student group ran true throughout the whole population it seems realistic to assume that the frequency of this type of a thalassaemia is also true for the whole population.
To test this further the frequency was calculated from the number of cord bloods which contained 3 to 5% Hb Bart's (74) and also from the levels of Hb S in A/S carriers.
Of Moreover, persistent splenomegaly is usual into adolescence, by which time all are hypersplenic, with low white cell and platelet counts. Twentysix of our patients have had to be splenectomised since they required regular transfusion to maintain their haemoglobin level above 6 g/dl.
The lack of splenic infarction may be because of a combination of the lower MCV of the sickle cells and the differences in the anatomy of splenic microcirculation as compared with that of the bones. However, the gross splenomegaly found in a proportion of our patients might be the result of chronic malaria. Finally it must be stressed that of these 103 patients only five are aged over 20 years and only one over 30. Early death therefore would appear to be common. Although this may be the result of environmental factors rather than a cellular event, it is clear that loss of two a genes does not ameliorate the sickle cell disease.
We would like to thank Professor Lucio Luzzatto for his helpful comments and Mr David Gravell for providing some of the data.
